# SCYNEXIS (stock symbol: SCYX) Logo in transparent PNG and SVG formats

## SCYNEXIS Logo large

### SCYNEXIS Logo large Download PNG (21.1 KB)

![SCYNEXIS Logo large Download PNG (21.1 KB)](/img/orig/SCYX_BIG-c5ec127e.png)

### SCYNEXIS Logo large Download SVG (5.6 KB)

![SCYNEXIS Logo large Download SVG (5.6 KB)](/img/orig/SCYX_BIG-f25d6938.svg)

## SCYNEXIS Logo icon format

### SCYNEXIS Logo icon format Download PNG (27.28 KB)

![SCYNEXIS Logo icon format Download PNG (27.28 KB)](/img/orig/SCYX-ccba82cf.png)

### SCYNEXIS Logo icon format Download SVG (1.56 KB)

![SCYNEXIS Logo icon format Download SVG (1.56 KB)](/img/orig/SCYX-aced6d7f.svg)

## SCYNEXIS Logo large for dark backgrounds

### SCYNEXIS Logo large for dark backgrounds Download PNG (21.1 KB)

![SCYNEXIS Logo large for dark backgrounds Download PNG (21.1 KB)](/img/orig/SCYX_BIG.D-2f46e64d.png)

### SCYNEXIS Logo large for dark backgrounds Download SVG (5.6 KB)

![SCYNEXIS Logo large for dark backgrounds Download SVG (5.6 KB)](/img/orig/SCYX_BIG.D-247703ae.svg)

## SCYNEXIS Logo icon format for dark backgrounds

### SCYNEXIS Logo icon format for dark backgrounds Download PNG (27.28 KB)

![SCYNEXIS Logo icon format for dark backgrounds Download PNG (27.28 KB)](/img/orig/SCYX.D-2ac4085c.png)

### SCYNEXIS Logo icon format for dark backgrounds Download SVG (1.56 KB)

![SCYNEXIS Logo icon format for dark backgrounds Download SVG (1.56 KB)](/img/orig/SCYX.D-5195dbbd.svg)

## About SCYNEXIS

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

1. Website domain: scynexis.com
2. Employees: 56
3. Marketcap: $0.10 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
